NCT00006337View on ClinicalTrials.gov

KW-6002 to Treat Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

January 31, 2002

Conditions
Parkinson's Disease
Interventions
DRUG

KW-6002

DRUG

IV Levodopa

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00006337 - KW-6002 to Treat Parkinson's Disease | Biotech Hunter | Biotech Hunter